Date published: 2025-9-8

021-6093-6350

SCBT Portrait Logo
Seach Input

NLR family CARD domain-containing (NLRC) 抑制因子

The NLR family CARD domain-containing (NLRC) proteins are a subgroup of the larger NLR (NOD-like receptor) family, which play a crucial role in the innate immune system. These proteins are characterized by the presence of a caspase recruitment domain (CARD) at their N-terminal. The CARD domain enables NLRC proteins to interact with other molecules involved in inflammatory and apoptotic pathways. NLRC proteins are primarily involved in recognizing pathogens and initiating immune responses, particularly by activating the NF-κB pathway and regulating cytokine production. Mutations or dysregulation in NLRC proteins can lead to various inflammatory diseases and immune disorders. Their study is vital for understanding disease mechanisms and developing targeted therapies for conditions involving the innate immune response.

NLR family CARD domain-containing (NLRC) Inhibitors are a class of chemical compounds specifically designed to decrease the functional activity of NLRC proteins. These inhibitors operate by targeting various biochemical and cellular pathways that are crucial for the proper functioning of NLRC proteins, particularly in the context of immune response and inflammation. Additionally, there has been interest in developing molecules that target specific interactions within the NLRC protein family, such as the formation of inflammasomes, aiming to disrupt protein-protein interactions crucial for NLRC function.

関連項目

产品名称CAS #产品编号数量价格应用排名

Tozasertib

639089-54-6sc-358750
sc-358750A
25 mg
50 mg
¥688.00
¥959.00
4
(1)

BAY 61-3606是一种Syk的选择性抑制剂,Syk是一种参与NLRC信号通路的激酶。通过抑制Syk,BAY 61-3606会破坏从上游受体到NLRC的信号转导,直接干扰蛋白质的激活。

PF-06465469

1407966-77-1sc-480369
5 mg
¥936.00
(0)

PF-06465469是一种选择性、强效的RIP2激酶抑制剂,可直接影响NLRC介导的信号通路。通过抑制RIP2,PF-06465469可阻断导致NLRC激活的下游事件,从而提供一种抑制该蛋白功能的靶向方法。这种化合物凸显了NLRC信号通路中激酶之间的复杂相互作用,并为调节细胞过程中NLRC的活性提供了具体策略。

Bemcentinib

1037624-75-1sc-507363
10 mg
¥10154.00
(0)

R428,也称为BGB324,是一种选择性AXL抑制剂,AXL是一种与NLRC信号通路相关的受体酪氨酸激酶。通过抑制AXL,R428会破坏从上游受体到NLRC的信号转导,直接干扰蛋白质的激活。

IKK-2 Inhibitor IV

507475-17-4sc-203083
500 µg
¥1467.00
12
(1)

TPCA-1是一种IKK-2的选择性抑制剂,IKK-2是一种参与NLRC下游NF-κB信号传导的激酶。通过抑制IKK-2,TPCA-1会破坏NLRC向NF-κB的信号转导,直接干扰蛋白质的下游效应。这种化合物说明了通过抑制特定激酶来调节NLRC介导的信号传导的潜力,并揭示了蛋白质参与细胞过程的复杂调节机制。

BX 795

702675-74-9sc-281689
sc-281689A
sc-281689C
sc-281689B
sc-281689D
sc-281689E
2 mg
5 mg
10 mg
25 mg
50 mg
100 mg
¥2471.00
¥3080.00
¥3734.00
¥5585.00
¥9951.00
¥16799.00
5
(1)

BX-795 是一种 PDK1 抑制剂,它通过破坏与 NLRC 激活有关的 PDK1-AKT 信号通路间接影响 NLRC。BX-795 对 PDK1 的抑制会导致调节 NLRC 功能的下游效应,这说明了靶向上游调节因子间接影响 NLRC 的潜力。